反応 #73369
ord-ecc093e4347d43ecbdfd0c5f92cfe340
反応方程式
反応物
試薬
溶媒
反応条件
後処理
- 1その他flushed with nitrogen
- 2workup.STIRRINGto stir at room temperature overnight
- 3温度The reaction is cooled in an ice bath
- 4その他quenched with a saturated solution of ammonium chloride (100 mL)
- 5workup.ADDITIONThe mixture is then diluted with ethyl acetate
- 6抽出the product is extracted (2×100 mL EtOAc)
- 7その他dried
- 8濃縮concentrated to a brown oil that
- 9workup.DISSOLUTIONis dissolved in 10 mL of DCM
- 10温度cooled in an ice bath
- 11workup.ADDITION10 mL of TFA is added
- 12その他completion of the reaction the DCM and TFA
- 13その他are removed
- 14workup.ADDITIONethyl acetate is added to the residue along with ammonium hydroxide
- 15その他to quench the remaining TFA
- 16workup.ADDITIONThe mixture is diluted with water
- 17抽出extracted with ethyl acetate (2×50 mL)
- 18その他The organic layers are removed
- 19その他dried
- 20濃縮concentrated
- 21その他The residue is absorbed onto silica
- 22その他separated via FCC (0-6% Methanol/DCM)
実験手順
Tert-butyl 4-(1H-indol-5-yloxy)-5H-pyrrolo[3,4-d]pyrimidine-6(7 H)-carboxylate (127 mg, 0.360 mmol) is dissolved in THF (8 mL), flushed with nitrogen and cooled to 0° C. Sodium hydride (23 mg, 0.575 mmol, 60% in mineral oil) is added and the mixture is stirred for 10 minutes. Phenyl 5-tert-butylisoxazol-3-ylcarbamate (140 mg, 0.538 mmol) is added neat and the reaction is allowed to stir at room temperature overnight. The reaction is cooled in an ice bath and quenched with a saturated solution of ammonium chloride (100 mL). The mixture is then diluted with ethyl acetate and the product is extracted (2×100 mL EtOAc). The organic layers are combined, dried and concentrated to a brown oil that is dissolved in 10 mL of DCM and cooled in an ice bath and 10 mL of TFA is added. Following completion of the reaction the DCM and TFA are removed and ethyl acetate is added to the residue along with ammonium hydroxide to quench the remaining TFA. The mixture is diluted with water and extracted with ethyl acetate (2×50 mL). The organic layers are removed, dried, and concentrated. The residue is absorbed onto silica and separated via FCC (0-6% Methanol/DCM) to obtain N-(5-tert-butylisoxazol-3-yl)-5-(6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-yloxy)-1H-indole-1-carboxamide. MS (ESI) m/z 419.2 (M+1); 1H NMR (400 MHz, DMSO-d6) δ ppm 8.56 (s, 1 H)8.29 (d, J=8.84 Hz, 1 H)8.17 (d, J=3.79 Hz, 1 H)7.47 (d, J=2.27 Hz, 1 H)7.15 (dd, J=8.97, 2.40 Hz, 1 H)6.76 (d, J=3.28 Hz, 1 H)6.68 (s, 1 H)4.07-4.14 (m, 4 H)1.34 (s, 9 H).